Page last updated: 2024-10-16

quinacrine and Hyperplasia

quinacrine has been researched along with Hyperplasia in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Senior, PV1
Sunter, JP1
Appleton, DR1
Watson, AJ1
Gryboski, JD1
Self, TW1
Clemett, A1
Herskovic, T1

Other Studies

2 other studies available for quinacrine and Hyperplasia

ArticleYear
Morphometric and kinetic studies on the changes induced in the intestinal mucosa of rats by intraperitoneal administration of quinacrine.
    Cell and tissue kinetics, 1984, Volume: 17, Issue:5

    Topics: Animals; Cell Division; Colon; DNA Replication; Female; Hyperplasia; Hypertrophy; Intestinal Mucosa;

1984
Selective immunoglobulin A deficiency and intestinal nodular lymphoid hyperplasia: correction of diarrhea with antibiotics and plasma.
    Pediatrics, 1968, Volume: 42, Issue:5

    Topics: Adolescent; Agammaglobulinemia; Diarrhea; Giardiasis; Humans; Hyperplasia; Infusions, Parenteral; In

1968